Adjuvant treatment of colorectal cancer.

Colorectal cancer (CRC) represents a major public health problem, accounting for more than 1 million new cases diagnosed and about a half million deaths worldwide each year. Despite surgery with curative intent, the risk of recurrence is high. The search for the most effective adjuvant therapy for the eradication of micrometastases is a priority, as is the identification of patients whose tumors are not going to recur after surgery.